InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Relay Therapeutics, Inc.

RLAY Clue Score52
United States Fiscal year ends December CIK 0001812364 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
Thomas Catinazzo
28 Oct 2026
Chief Financial Officer
Sell
1,469
$18.62
$27.35K
Donald A Bergstrom
28 Oct 2026
President, R&D
Sell
2,252
$18.62
$41.93K
Peter Rahmer
28 Oct 2026
See remarks
Sell
753
$18.62
$14.02K
SVF Pauling (Cayman) Ltd
25 Aug 2026
10% owner
Sell indirect
6,000,000
$19.40
$116.40M
Donald A Bergstrom
28 Jul 2026
President, R&D
Sell
2,237
$18.61
$41.63K
Peter Rahmer
28 Jul 2026
See remarks
Sell
748
$18.61
$13.92K
Thomas Catinazzo
28 Jul 2026
Chief Financial Officer
Sell
1,459
$18.61
$27.15K
Donald A Bergstrom
28 Apr 2026
President, R&D
Sell
1,490
$14.79
$22.04K
Peter Rahmer
28 Apr 2026
See remarks
Sell
753
$14.79
$11.14K
Thomas Catinazzo
28 Apr 2026
Chief Financial Officer
Sell
972
$14.79
$14.38K
Thomas Catinazzo
28 Jan 2026
Chief Financial Officer
Sell
1,695
$8.45
$14.32K
Peter Rahmer
28 Jan 2026
See remarks
Sell
1,354
$8.45
$11.44K
Donald A Bergstrom
28 Jan 2026
President, R&D
Sell
2,686
$8.45
$22.70K
Thomas Catinazzo
27 Jan 2026
Chief Financial Officer
Sell
13,820
$7.62
$105.31K
Peter Rahmer
27 Jan 2026
See remarks
Sell
11,684
$7.62
$89.03K
Donald A Bergstrom
27 Jan 2026
President, R&D
Sell
18,895
$7.62
$143.98K
Sanjiv Patel
6 Jan 2026
President and CEO
Sell
43,168
$7.82
$337.57K
Show all 39 transactions →

What was left out

Form 4 filings counted 44
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 6
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 272,802
History held since 20 Jul 2020